Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II feasibility trial of induction chemotherapy plus extrapleural pneumonectomy and postoperative radiotherapy in malignant pleural mesothelioma
2004-004273-28Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and cisplatin in pleural mesothelioma, sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Success of treatment. Started Aug 2005; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2004-004273-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004273-28.